vancomycin has been researched along with Ear Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kocyigit, I; Oymak, O; Sipahioglu, M; Somdas, M; Tokgoz, B; Ucar, C; Unal, A; Utas, C; Vural, A | 1 |
| Begg, EJ; Duffull, SB | 2 |
| Freeman, CD; Nightingale, CH; Quintiliani, R | 1 |
| Sacristan, JA; Soto, J | 1 |
| Brent, J; Burkhart, KK; Kulig, K; Metcalf, S; O'Meara, O; Rumack, BH; Shurnas, E | 1 |
| Davey, PG; Williams, AH | 1 |
| Brown, DP; Hall, JW; Mackey-Hargadine, JR | 1 |
| Edwards, DJ; Pancorbo, S | 1 |
3 review(s) available for vancomycin and Ear Diseases
| Article | Year |
|---|---|
Vancomycin toxicity. What is the evidence for dose dependency?
Topics: Dose-Response Relationship, Drug; Ear Diseases; Ear, Inner; Humans; Hypotension; Kidney Diseases; Vancomycin | 1994 |
Vancomycin therapeutic drug monitoring: is it necessary?
Topics: Animals; Bacterial Infections; Child, Preschool; Drug Monitoring; Ear Diseases; Humans; Infant; Infant, Newborn; Kidney Diseases; Vancomycin | 1993 |
A review of the safety profile of teicoplanin.
Topics: Animals; Anti-Bacterial Agents; Drug Hypersensitivity; Ear Diseases; Glycopeptides; Humans; Kidney Diseases; Safety; Skin Diseases; Teicoplanin; Vancomycin | 1991 |
2 trial(s) available for vancomycin and Ear Diseases
| Article | Year |
|---|---|
Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.
Topics: Acetylcysteine; Amikacin; Anti-Bacterial Agents; Ear Diseases; Free Radical Scavengers; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 2011 |
A review of the safety profile of teicoplanin.
Topics: Animals; Anti-Bacterial Agents; Drug Hypersensitivity; Ear Diseases; Glycopeptides; Humans; Kidney Diseases; Safety; Skin Diseases; Teicoplanin; Vancomycin | 1991 |
5 other study(ies) available for vancomycin and Ear Diseases
| Article | Year |
|---|---|
Why monitor peak vancomycin concentrations?
Topics: Drug Monitoring; Ear Diseases; Humans; Infusions, Intravenous; Kidney Diseases; Vancomycin | 1995 |
Vancomycin peak concentration and ototoxicity prevention.
Topics: Dose-Response Relationship, Drug; Ear Diseases; Humans; Vancomycin | 1992 |
Exchange transfusion and multidose activated charcoal following vancomycin overdose.
Topics: Charcoal; Creatinine; Drug Overdose; Ear Diseases; Exchange Transfusion, Whole Blood; Half-Life; Humans; Infant; Kidney Diseases; Male; Vancomycin | 1992 |
Pediatric applications of serial auditory brainstem and middle-latency evoked response recordings.
Topics: Auditory Diseases, Central; Brain Stem; Child; Child, Preschool; Craniocerebral Trauma; Developmental Disabilities; Ear Diseases; Evoked Potentials, Auditory; Female; Humans; Hydrocephalus; Infant; Infant, Newborn; Intraoperative Care; Male; Peripheral Nervous System Diseases; Vancomycin | 1985 |
Routine monitoring of serum vancomycin concentrations: waiting for proof of its value.
Topics: Drug Administration Schedule; Drug Therapy; Ear Diseases; Humans; Kidney Diseases; Vancomycin | 1987 |